AnHeart Announces Upcoming Presentation of Preliminary Results from Phase II Trial of Taletrectinib in ROS1+ NSCLC at the ASCO 2021 Virtual Meeting
HANGZHOU, China and NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) — AnHeart Therapeutics Co., Ltd. (“AnHeart”), a clinical stage oncology…